Evidence map›Paper›PMID 26739898›Full record

ArticleScientific reports2016

High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells.

Yu-Ching Chen, Sarah Statt, Reen Wu, Hao-Teng Chang, Jiunn-Wang Liao, Chien-Neng Wang, Woei-Cherng Shyu, Chen-Chen Lee

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yu-Ching ChenGraduate Institute of Immunology, College of Medicine, China Medicine University, Taichung, Taiwan.
Sarah StattCenter for Comparative Respiratory Biology and Medicine, Internal Medicine, College of Medicine, University of California at Davis, USA.
Reen WuCenter for Comparative Respiratory Biology and Medicine, Internal Medicine, College of Medicine, University of California at Davis, USA.
Hao-Teng ChangInstitute of Basic Medical Science, College of Medicine, China Medicine University, Taichung, Taiwan.
Jiunn-Wang LiaoInstitute of Veterinary Pathology, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan.
Chien-Neng WangInstitute of Basic Medical Science, College of Medicine, China Medicine University, Taichung, Taiwan.
Woei-Cherng ShyuGraduate Institute of Immunology, College of Medicine, China Medicine University, Taichung, Taiwan.
Chen-Chen LeeGraduate Institute of Immunology, College of Medicine, China Medicine University, Taichung, Taiwan.
China Medical University · TWInstitute of Basic Medical Sciences of the Chinese Academy of Medical SciencesUniversity of California, Davis · USNational Chung Hsing University · TW

Funding

ENVIRONMENTAL TOXICOLOGYT32ES007059 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura S Van Winkle · 1985 to 2026
$7.9M
NIEHS NIH HHS T32 ES007059
6 · The paper itself

Abstract

Epithelial-mesenchymal transition (EMT) is implicated in bronchial remodeling and loss of lung function in chronic inflammatory airway diseases. Previous studies showed the involvement of the high mobility group box 1 (HMGB1) protein in the pathology of chronic pulmonary inflammatory diseases. However, the role of HMGB1 in EMT of human airway epithelial cells is still unclear. In this study, we used RNA sequencing to show that HMGB1 treatment regulated EMT-related gene expression in human primary-airway epithelial cells. The top five upregulated genes were SNAI2, FGFBP1, VIM, SPARC (osteonectin), and SERPINE1, while the downregulated genes included OCLN, TJP1 (ZO-1), FZD7, CDH1 (E-cadherin), and LAMA5. We found that HMGB1 induced downregulation of E-cadherin and ZO-1, and upregulation of vimentin mRNA transcription and protein translation in a dose-dependent manner. Additionally, we observed that HMGB1 induced AKT phosphorylation, resulting in GSK3β inactivation, cytoplasmic accumulation, and nuclear translocation of β-catenin to induce EMT in human airway epithelial cells. Treatment with PI3K inhibitor (LY294006) and β-catenin shRNA reversed HMGB1-induced EMT. Moreover, HMGB1 induced expression of receptor for advanced glycation products (RAGE), but not that of Toll-like receptor (TLR) 2 or TLR4, and RAGE shRNA inhibited HMGB1-induced EMT in human airway epithelial cells. In conclusion, we found that HMGB1 induced EMT through RAGE and the PI3K/AKT/GSK3β/β-catenin signaling pathway.

Indexed as

Epithelial-Mesenchymal TransitionAntigens, Neoplasmbeta CateninCell LineCell MovementEpithelial CellsGene ExpressionGlycogen Synthase Kinase 3 betaHMGB1 ProteinHumansMitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktRespiratory MucosaSignal TransductionAntigens, Neoplasmbeta CateninCTNNB1 protein, humanGlycogen Synthase Kinase 3 betaGSK3B protein, humanHMGB1 ProteinHMGB1 protein, humanMitogen-Activated Protein KinasesMOK protein, humanProto-Oncogene Proteins c-akt

Identifiers

PMID26739898
PMCPMC4703978
OpenAlexW2230420449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.